Status:
COMPLETED
ENO Breathe vs Usual Care in COVID-19 Recovery
Lead Sponsor:
Imperial College London
Collaborating Sponsors:
Imperial College Healthcare NHS Trust
Conditions:
COVID-19 Recovery
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
A randomised clinical trial to assess the impact of an online singing, breathing and wellbeing programme (ENO Breathe) developed specifically for people recovering from COVID-19.
Detailed Description
BACKGROUND: ENO Breathe is a breathing and wellbeing programme developed specifically for people recovering from COVID-19, who are still suffering from breathlessness and associated anxiety. Delivere...
Eligibility Criteria
Inclusion
- Adults recovering from COVID-19 with ongoing breathlessness and/or anxiety.
- Referred from a specialist COVID-19 clinics aligned with the project, after appropriate clinical evaluation and investigation
- Internet access with appropriate device (e.g. computer or tablet)
Exclusion
- \- Unable to participate due to comorbidity (e.g. life limiting illness, cognitive impairment)
Key Trial Info
Start Date :
April 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2021
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04830033
Start Date
April 28 2021
End Date
September 23 2021
Last Update
December 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart and Lung Institute, Imperial College London
London, United Kingdom, SW3 6NP